APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Somatostatin Drugs Market Analysis and Forecast 2026-2032

Report ID 17403694022 January 2026193 pages

Choose your research edition.

Industry ResearchSomatostatin Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin Drugs Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Somatostatin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Somatostatin Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Somatostatin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Somatostatin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Somatostatin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Somatostatin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Somatostatin Drugs include Novartis, Pfizer, TianTaiShan, Ispen and HYBIO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Somatostatin Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Somatostatin Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Somatostatin Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Somatostatin Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Somatostatin Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Somatostatin Drugs sales, projected growth trends, production technology, application and end-user industry.

Somatostatin Drugs Segment by Company

Novartis

Pfizer

TianTaiShan

Ispen

HYBIO

Somatostatin Drugs Segment by Type

Octreotide

Lanreotide

Pasireotide

Other

Somatostatin Drugs Segment by Application

Hospital

Pharmacy

Other

Somatostatin Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Somatostatin Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Somatostatin Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Somatostatin Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Somatostatin Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Octreotide Major Manufacturers Table 3. Lanreotide Major Manufacturers Table 4. Pasireotide Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Somatostatin Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Pharmacy Major Manufacturers Table 9. Other Major Manufacturers Table 10. Somatostatin Drugs Industry Trends Table 11. Somatostatin Drugs Industry Drivers Table 12. Somatostatin Drugs Industry Opportunities and Challenges Table 13. Somatostatin Drugs Industry Restraints Table 14. Global Somatostatin Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Somatostatin Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Somatostatin Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Somatostatin Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Somatostatin Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Somatostatin Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Somatostatin Drugs Sales by Region (2021-2026) & (K Units) Table 21. Global Somatostatin Drugs Sales by Region (2027-2032) & (K Units) Table 22. Global Somatostatin Drugs Sales Market Share by Region (2021-2026) Table 23. Global Somatostatin Drugs Sales Market Share by Region (2027-2032) Table 24. Global Somatostatin Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Somatostatin Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Somatostatin Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Somatostatin Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Somatostatin Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Somatostatin Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Somatostatin Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Somatostatin Drugs Manufacturers, Product Type & Application Table 32. Global Somatostatin Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Somatostatin Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Somatostatin Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Somatostatin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Somatostatin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Somatostatin Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Somatostatin Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Somatostatin Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Somatostatin Drugs Sales by Type (2021-2026) & (K Units) Table 42. Global Somatostatin Drugs Sales by Type (2027-2032) & (K Units) Table 43. Global Somatostatin Drugs Sales Market Share by Type (2021-2026) Table 44. Global Somatostatin Drugs Sales Market Share by Type (2027-2032) Table 45. Global Somatostatin Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Somatostatin Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Somatostatin Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Somatostatin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Somatostatin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Somatostatin Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Somatostatin Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Somatostatin Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Somatostatin Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Somatostatin Drugs Sales by Application (2027-2032) & (K Units) Table 55. Global Somatostatin Drugs Sales Market Share by Application (2021-2026) Table 56. Global Somatostatin Drugs Sales Market Share by Application (2027-2032) Table 57. Global Somatostatin Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Somatostatin Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Novartis Company Information Table 60. Novartis Business Overview Table 61. Novartis Somatostatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Novartis Somatostatin Drugs Product Portfolio Table 63. Novartis Recent Development Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Somatostatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Pfizer Somatostatin Drugs Product Portfolio Table 68. Pfizer Recent Development Table 69. TianTaiShan Company Information Table 70. TianTaiShan Business Overview Table 71. TianTaiShan Somatostatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. TianTaiShan Somatostatin Drugs Product Portfolio Table 73. TianTaiShan Recent Development Table 74. Ispen Company Information Table 75. Ispen Business Overview Table 76. Ispen Somatostatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Ispen Somatostatin Drugs Product Portfolio Table 78. Ispen Recent Development Table 79. HYBIO Company Information Table 80. HYBIO Business Overview Table 81. HYBIO Somatostatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. HYBIO Somatostatin Drugs Product Portfolio Table 83. HYBIO Recent Development Table 84. North America Somatostatin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Somatostatin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Somatostatin Drugs Sales by Type (2021-2026) & (K Units) Table 87. North America Somatostatin Drugs Sales by Type (2027-2032) & (K Units) Table 88. North America Somatostatin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 89. North America Somatostatin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 90. North America Somatostatin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Somatostatin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Somatostatin Drugs Sales by Application (2021-2026) & (K Units) Table 93. North America Somatostatin Drugs Sales by Application (2027-2032) & (K Units) Table 94. North America Somatostatin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 95. North America Somatostatin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 96. North America Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Somatostatin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. North America Somatostatin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. North America Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 100. North America Somatostatin Drugs Sales by Country (2021-2026) & (K Units) Table 101. North America Somatostatin Drugs Sales by Country (2027-2032) & (K Units) Table 102. North America Somatostatin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 103. North America Somatostatin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 104. United States Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 105. Canada Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 106. Europe Somatostatin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Somatostatin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Somatostatin Drugs Sales by Type (2021-2026) & (K Units) Table 109. Europe Somatostatin Drugs Sales by Type (2027-2032) & (K Units) Table 110. Europe Somatostatin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 111. Europe Somatostatin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 112. Europe Somatostatin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Somatostatin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Somatostatin Drugs Sales by Application (2021-2026) & (K Units) Table 115. Europe Somatostatin Drugs Sales by Application (2027-2032) & (K Units) Table 116. Europe Somatostatin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 117. Europe Somatostatin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 118. Europe Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Somatostatin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. Europe Somatostatin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. Europe Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. Europe Somatostatin Drugs Sales by Country (2021-2026) & (K Units) Table 123. Europe Somatostatin Drugs Sales by Country (2027-2032) & (K Units) Table 124. Europe Somatostatin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 125. Europe Somatostatin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 126. Germany Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 127. France Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 128. U.K. Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 129. Italy Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 131. China Somatostatin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 132. China Somatostatin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 133. China Somatostatin Drugs Sales by Type (2021-2026) & (K Units) Table 134. China Somatostatin Drugs Sales by Type (2027-2032) & (K Units) Table 135. China Somatostatin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 136. China Somatostatin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 137. China Somatostatin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. China Somatostatin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. China Somatostatin Drugs Sales by Application (2021-2026) & (K Units) Table 140. China Somatostatin Drugs Sales by Application (2027-2032) & (K Units) Table 141. China Somatostatin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 142. China Somatostatin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Somatostatin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Somatostatin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Somatostatin Drugs Sales by Type (2021-2026) & (K Units) Table 146. Asia Somatostatin Drugs Sales by Type (2027-2032) & (K Units) Table 147. Asia Somatostatin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Asia Somatostatin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Asia Somatostatin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Somatostatin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Somatostatin Drugs Sales by Application (2021-2026) & (K Units) Table 152. Asia Somatostatin Drugs Sales by Application (2027-2032) & (K Units) Table 153. Asia Somatostatin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Asia Somatostatin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Asia Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Somatostatin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Somatostatin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Asia Somatostatin Drugs Sales by Country (2021-2026) & (K Units) Table 160. Asia Somatostatin Drugs Sales by Country (2027-2032) & (K Units) Table 161. Asia Somatostatin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Asia Somatostatin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Japan Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 164. South Korea Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 165. India Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 166. Australia Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 167. China Taiwan Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Somatostatin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Somatostatin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Somatostatin Drugs Sales by Type (2021-2026) & (K Units) Table 172. SAMEA Somatostatin Drugs Sales by Type (2027-2032) & (K Units) Table 173. SAMEA Somatostatin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 174. SAMEA Somatostatin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 175. SAMEA Somatostatin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Somatostatin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Somatostatin Drugs Sales by Application (2021-2026) & (K Units) Table 178. SAMEA Somatostatin Drugs Sales by Application (2027-2032) & (K Units) Table 179. SAMEA Somatostatin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 180. SAMEA Somatostatin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 181. SAMEA Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Somatostatin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Somatostatin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. SAMEA Somatostatin Drugs Sales by Country (2021-2026) & (K Units) Table 186. SAMEA Somatostatin Drugs Sales by Country (2027-2032) & (K Units) Table 187. SAMEA Somatostatin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 188. SAMEA Somatostatin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Brazil Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 190. Argentina Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 191. Chile Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 192. Colombia Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 193. Peru Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 195. Israel Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 196. UAE Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 197. Turkey Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 198. Iran Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 199. Egypt Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Somatostatin Drugs Distributors List Table 203. Somatostatin Drugs Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Somatostatin Drugs Image Figure 2. Global Somatostatin Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Somatostatin Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Octreotide Image Figure 5. Lanreotide Image Figure 6. Pasireotide Image Figure 7. Other Image Figure 8. Global Somatostatin Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Somatostatin Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Pharmacy Image Figure 12. Other Image Figure 13. Global Somatostatin Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Somatostatin Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Somatostatin Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Somatostatin Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Somatostatin Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Somatostatin Drugs Sales (2021-2032) & (K Units) Figure 19. Global Somatostatin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Somatostatin Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Somatostatin Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Europe Somatostatin Drugs Sales YoY (2021-2032) & (K Units) Figure 23. China Somatostatin Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Somatostatin Drugs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Somatostatin Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Global Somatostatin Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Somatostatin Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Somatostatin Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Somatostatin Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Somatostatin Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Somatostatin Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Somatostatin Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Somatostatin Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Somatostatin Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Somatostatin Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Somatostatin Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Somatostatin Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Somatostatin Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Somatostatin Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Somatostatin Drugs Revenue Share by Type (2021-2032) Figure 42. North America Somatostatin Drugs Sales Share by Type (2021-2032) Figure 43. North America Somatostatin Drugs Revenue Share by Application (2021-2032) Figure 44. North America Somatostatin Drugs Sales Share by Application (2021-2032) Figure 45. North America Somatostatin Drugs Revenue Share by Country (2021-2032) Figure 46. North America Somatostatin Drugs Sales Share by Country (2021-2032) Figure 47. Europe Somatostatin Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Somatostatin Drugs Sales Share by Type (2021-2032) Figure 49. Europe Somatostatin Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Somatostatin Drugs Sales Share by Application (2021-2032) Figure 51. Europe Somatostatin Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Somatostatin Drugs Sales Share by Country (2021-2032) Figure 53. China Somatostatin Drugs Revenue Share by Type (2021-2032) Figure 54. China Somatostatin Drugs Sales Share by Type (2021-2032) Figure 55. China Somatostatin Drugs Revenue Share by Application (2021-2032) Figure 56. China Somatostatin Drugs Sales Share by Application (2021-2032) Figure 57. Asia Somatostatin Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Somatostatin Drugs Sales Share by Type (2021-2032) Figure 59. Asia Somatostatin Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Somatostatin Drugs Sales Share by Application (2021-2032) Figure 61. Asia Somatostatin Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Somatostatin Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Somatostatin Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Somatostatin Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Somatostatin Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Somatostatin Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Somatostatin Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Somatostatin Drugs Sales Share by Country (2021-2032) Figure 69. Somatostatin Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Somatostatin Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Octreotide
  • Lanreotide
  • Pasireotide
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Novartis
  • Pfizer
  • TianTaiShan
  • Ispen
  • HYBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Somatostatin Drugs Market by Type
  3. 1.2.1 Global Somatostatin Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Octreotide
  5. 1.2.3 Lanreotide
  6. 1.2.4 Pasireotide
  7. 1.2.5 Other
  8. 1.3 Somatostatin Drugs Market by Application
  9. 1.3.1 Global Somatostatin Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Pharmacy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Somatostatin Drugs Market Dynamics
  1. 2.1 Somatostatin Drugs Industry Trends
  2. 2.2 Somatostatin Drugs Industry Drivers
  3. 2.3 Somatostatin Drugs Industry Opportunities and Challenges
  4. 2.4 Somatostatin Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Somatostatin Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Somatostatin Drugs Revenue by Region
  3. 3.2.1 Global Somatostatin Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Somatostatin Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Somatostatin Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Somatostatin Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Somatostatin Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Somatostatin Drugs Sales by Region
  9. 3.4.1 Global Somatostatin Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Somatostatin Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Somatostatin Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Somatostatin Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Somatostatin Drugs Revenue by Manufacturers
  2. 4.1.1 Global Somatostatin Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Somatostatin Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Somatostatin Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Somatostatin Drugs Sales by Manufacturers
  6. 4.2.1 Global Somatostatin Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Somatostatin Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Somatostatin Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Somatostatin Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Somatostatin Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Somatostatin Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Somatostatin Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Somatostatin Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Somatostatin Drugs Market CR5 and HHI
  16. 4.8.2 2025 Somatostatin Drugs Tier 1, Tier 2, and Tier 3
5 Somatostatin Drugs Market by Type
  1. 5.1 Global Somatostatin Drugs Revenue by Type
  2. 5.1.1 Global Somatostatin Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Somatostatin Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Somatostatin Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Somatostatin Drugs Sales by Type
  6. 5.2.1 Global Somatostatin Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Somatostatin Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Somatostatin Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Somatostatin Drugs Price by Type
6 Somatostatin Drugs Market by Application
  1. 6.1 Global Somatostatin Drugs Revenue by Application
  2. 6.1.1 Global Somatostatin Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Somatostatin Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Somatostatin Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Somatostatin Drugs Sales by Application
  6. 6.2.1 Global Somatostatin Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Somatostatin Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Somatostatin Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Somatostatin Drugs Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Somatostatin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Somatostatin Drugs Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Somatostatin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Somatostatin Drugs Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 TianTaiShan
  14. 7.3.1 TianTaiShan Company Information
  15. 7.3.2 TianTaiShan Business Overview
  16. 7.3.3 TianTaiShan Somatostatin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TianTaiShan Somatostatin Drugs Product Portfolio
  18. 7.3.5 TianTaiShan Recent Developments
  19. 7.4 Ispen
  20. 7.4.1 Ispen Company Information
  21. 7.4.2 Ispen Business Overview
  22. 7.4.3 Ispen Somatostatin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ispen Somatostatin Drugs Product Portfolio
  24. 7.4.5 Ispen Recent Developments
  25. 7.5 HYBIO
  26. 7.5.1 HYBIO Company Information
  27. 7.5.2 HYBIO Business Overview
  28. 7.5.3 HYBIO Somatostatin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HYBIO Somatostatin Drugs Product Portfolio
  30. 7.5.5 HYBIO Recent Developments
8 North America
  1. 8.1 North America Somatostatin Drugs Market Size by Type
  2. 8.1.1 North America Somatostatin Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Somatostatin Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Somatostatin Drugs Price by Type (2021-2032)
  5. 8.2 North America Somatostatin Drugs Market Size by Application
  6. 8.2.1 North America Somatostatin Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Somatostatin Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Somatostatin Drugs Price by Application (2021-2032)
  9. 8.3 North America Somatostatin Drugs Market Size by Country
  10. 8.3.1 North America Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Somatostatin Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Somatostatin Drugs Market Size by Type
  2. 9.1.1 Europe Somatostatin Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Somatostatin Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Somatostatin Drugs Price by Type (2021-2032)
  5. 9.2 Europe Somatostatin Drugs Market Size by Application
  6. 9.2.1 Europe Somatostatin Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Somatostatin Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Somatostatin Drugs Price by Application (2021-2032)
  9. 9.3 Europe Somatostatin Drugs Market Size by Country
  10. 9.3.1 Europe Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Somatostatin Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Somatostatin Drugs Market Size by Type
  2. 10.1.1 China Somatostatin Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Somatostatin Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Somatostatin Drugs Price by Type (2021-2032)
  5. 10.2 China Somatostatin Drugs Market Size by Application
  6. 10.2.1 China Somatostatin Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Somatostatin Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Somatostatin Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Somatostatin Drugs Market Size by Type
  2. 11.1.1 Asia Somatostatin Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Somatostatin Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Somatostatin Drugs Price by Type (2021-2032)
  5. 11.2 Asia Somatostatin Drugs Market Size by Application
  6. 11.2.1 Asia Somatostatin Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Somatostatin Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Somatostatin Drugs Price by Application (2021-2032)
  9. 11.3 Asia Somatostatin Drugs Market Size by Country
  10. 11.3.1 Asia Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Somatostatin Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Somatostatin Drugs Market Size by Type
  2. 12.1.1 SAMEA Somatostatin Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Somatostatin Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Somatostatin Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Somatostatin Drugs Market Size by Application
  6. 12.2.1 SAMEA Somatostatin Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Somatostatin Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Somatostatin Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Somatostatin Drugs Market Size by Country
  10. 12.3.1 SAMEA Somatostatin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Somatostatin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Somatostatin Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Somatostatin Drugs Value Chain Analysis
  2. 13.1.1 Somatostatin Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Somatostatin Drugs Production Mode & Process
  6. 13.2 Somatostatin Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Somatostatin Drugs Distributors
  9. 13.2.3 Somatostatin Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst